Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
8.80
+0.02 (0.23%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Rallybio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -8.98 | -57.78 | -74.56 | -66.65 | -47.01 | |
| Depreciation & Amortization | 0.09 | 0.13 | 0.15 | 0.17 | 0.11 | |
| Loss (Gain) From Sale of Investments | -22.92 | -1.61 | -3.09 | -0.44 | - | |
| Loss (Gain) on Equity Investments | 0.87 | 2.24 | 2.04 | 1.08 | 1.51 | |
| Stock-Based Compensation | 5.31 | 7.99 | 10.92 | 9.5 | 3.65 | |
| Change in Accounts Payable | -0.15 | -0.7 | -0.1 | 0.49 | -0.98 | |
| Change in Unearned Revenue | -0.85 | 1.06 | - | - | - | |
| Change in Other Net Operating Assets | -3.19 | -0.62 | 4.38 | -1.42 | -2.8 | |
| Operating Cash Flow | -29.81 | -49.28 | -60.27 | -57.28 | -45.53 | |
| Capital Expenditures | - | - | -0.01 | -0.05 | -0.33 | |
| Investment in Securities | 47.27 | 33.49 | 27.67 | -112.12 | -2 | |
| Investing Cash Flow | 47.27 | 33.49 | 27.66 | -112.17 | -2.33 | |
| Issuance of Common Stock | 0.02 | 5.47 | 0.28 | 51.77 | 86.2 | |
| Other Financing Activities | - | -0.27 | -0.14 | -0.69 | -3.23 | |
| Financing Cash Flow | 0.02 | 5.2 | 0.14 | 51.08 | 82.97 | |
| Net Cash Flow | 17.47 | -10.59 | -32.46 | -118.38 | 35.1 | |
| Free Cash Flow | -29.81 | -49.28 | -60.28 | -57.34 | -45.87 | |
| Free Cash Flow Margin | -3474.71% | -7748.74% | - | - | - | |
| Free Cash Flow Per Share | -5.30 | -9.05 | -11.92 | -14.41 | -14.38 | |
| Levered Free Cash Flow | -20.34 | -28.05 | -34.15 | -33.77 | -28.91 | |
| Unlevered Free Cash Flow | -20.34 | -28.05 | -34.15 | -33.77 | -28.91 | |
| Change in Working Capital | -4.19 | -0.26 | 4.28 | -0.94 | -3.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.